Funding Rounds
Rappta Therapeutics

Rappta Therapeutics Series A (2020, $10M)

Rappta Therapeutics

Anti-cancer drugs ddevelopers activating protein phosphatase 2A (PP2A)

View Company Profile

GET THE TOP 10 COMPANIES OF THE WEEK IN YOUR EMAIL, EVERY TUESDAY.

OR DOWNLOAD OUR DATABASE OF 17,000 COMPANIES →

Summary

Stage: Series A

Raised Amount: $10.53M

Raised Date: 2020-01-01

Investors